Search Results for "Dcis Recurrence After Mastectomy"

16:25 EDT 2nd August 2015 | BioPortfolio

Matching Channels

Tumor recurrence

Oncotrace

For optimal treatment in cancerology, clinicians need specific, precise, sensitive methods to quantify treatment response, monitor residual disease and detect early recurrence in patients. Residual ...

WolffParkinsonWhite WPW syndrome

Wolff–Parkinson–White syndrome (WPW) is a syndrome of pre-excitation of ventricles of the heart due to an accessory pathway known as the bundle of Kent. This accessory pathway is an abno...

UroGenRA - Genitourinary cancer array

UroGenRA is a CGI custom-designed oligonucleotide array for implementation within a clinical laboratory as an array CGH-based diagnostic/prognostic tool for kidney, prostate, and bladder cancers. It...

Tumor markers

Tumor markers are substances produced by tumor cells or by other cells of the body in response to cancer or certain benign (noncancerous) conditions. These substances can be found in the blood, in t...

Matching News

New trial uses breast MRI and genomics for treatment decision-making in DCIS

(ECOG-ACRIN Cancer Research Group) Women with DCIS receive same treatments as those with early-stage invasive cancer. Decisions about lumpectomy/mastectomy often based on mammography alone. Trial exam...

Molecular Phenotypes of DCIS Predict Recurrence

Find out what types of recurrence are predicted and why it matters. Annals of Oncology

Breast Cancer Research and Treatment Publishes Oncotype DX® DCIS Score™ Study

REDWOOD CITY, Calif., July 14, 2015 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Breast Cancer Research and Treatment published results from a second large clinical va...

Oncotype DX® Presentations at ASCO in Breast and Prostate Cancer Reinforce Genomic Health's Leadership in Optimizing Cancer Treatment

REDWOOD CITY, Calif., June 1, 2015 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced results from multiple Oncotype DX® studies presented at the 2015 American Society of Cl...

DCIS Predicts Risk of Local Recurrence (CME/CE)

(MedPage Today) -- Intermediate risk score may be best predictor

Arimidex® More Effective than Tamoxifen in Prevention of Recurrence in Early Breast Cancer

For patients with a common type of breast cancer known as ductal carcinoma in situ (DCIS), the drug Arimidex® (anastrozole) may provide better protection against recurrence than tamoxifen. These find...

Potential Practice Change in Management of DCIS

In a major clinical trial, an aromatase inhibitor was more effective than tamoxifen in preventing disease recurrence. Medscape Medical News

Nipple-Sparing Mastectomy as Good as Full Breast Removal: Study

FRIDAY, May 1, 2015 -- Women with early stage breast cancer who chose to preserve the nipple during a mastectomy had similar survival or recurrence rates to women who underwent full breast removal, a ...

Matching PubMed Articles

The current clinical value of the DCIS Score.

The management of ductal carcinoma in situ (DCIS) can be controversial. Widespread adoption of mammographic screening has made DCIS a more frequent diagnosis, and increasingly smaller, lower-grade les...

Factors Affecting Informed Decision-Making in Women with Increased Breast Cancer Risk or DCIS Pursuing Contralateral Prophylactic Mastectomy.

Despite lack of survival benefit, an increasing number of women diagnosed with ductal carcinoma in situ (DCIS) opt for removal of the unaffected breast in addition to the breast with known pathology, ...

Genomic differences between pure ductal carcinoma in situ and synchronous ductal carcinoma in situ with invasive breast cancer.

Although ductal carcinoma in situ (DCIS) precedes invasive ductal carcinoma (IDC), the related genomic alterations remain unknown. To identify the genomic landscape of DCIS and better understand the m...

Chest wall recurrence location and the lower-bound target of preventive radiotherapy after transverse incision in modified radical mastectomy.

We investigated the relationship between the lower-bound target of preventive radiation to the chest wall after modified radical mastectomy with a transverse incision and preoperative breast carcinoma...

Predictors for local invasive recurrence of ductal carcinoma in situ of the breast: a meta-analysis.

The introduction of mammographic screening has considerably increased the detection rate of ductal carcinoma in situ (DCIS), which has a high probability of recurrence. We carried out a meta-analysis ...

Search Whole site using Google

Loading

Advertisement
 
Advertisement
 
Advertisement Advertisement